What Is Defibrillation?

Defibrillation is a medical intervention that delivers a controlled electrical shock to the heart to terminate life-threatening arrhythmias and restore normal cardiac rhythm. It is the primary treatment for ventricular fibrillation and pulseless ventricular tachycardia, both of which cause the heart muscle to contract chaotically rather than in the coordinated pattern needed to pump blood. Without defibrillation, these arrhythmias are fatal within minutes. The technique draws on cardiology, biomedical engineering, and electrical engineering, combining precise waveform design with an understanding of cardiac electrophysiology.

The underlying mechanism involves applying a sufficient electric field across the myocardium to simultaneously depolarize a critical mass of cardiac cells, overriding the fibrillatory wavefronts and allowing the heart's natural pacemaker to reassert control. Research detailed at the NCBI resource on defibrillation modeling has used computational multiscale cardiac models to characterize how shock waveforms interact with tissue and to develop the virtual electrode polarization theory for defibrillation.

Fibrillation and the Need for Intervention

Fibrillation occurs when the heart's electrical system breaks down into disorganized, self-sustaining activation patterns. Ventricular fibrillation eliminates effective cardiac output entirely, making it a direct cause of sudden cardiac arrest. Atrial fibrillation, while less immediately life-threatening, can lead to stroke and heart failure and may also be treated with electrical cardioversion, a lower-energy variant of the defibrillation shock. The probability of successful defibrillation declines sharply with time: each minute without defibrillation reduces survival rates by approximately 7 to 10 percent, which drives the engineering imperative for rapid and widely available devices.

Defibrillation Waveforms and Device Types

Early defibrillators delivered monophasic waveforms, in which current flows in a single direction. Modern devices use biphasic waveforms, in which current reverses direction partway through the pulse. Biphasic truncated exponential waveforms require approximately half the energy of monophasic shocks to achieve the same defibrillation efficacy, reducing the risk of myocardial injury and enabling smaller, lighter devices. The NHLBI overview of defibrillators describes the major device categories: in-hospital defibrillators, automated external defibrillators (AEDs) for public use, and wearable cardioverter-defibrillators for patients at temporary elevated risk.

Automated external defibrillators analyze the patient's cardiac rhythm, determine whether a shock is indicated, and guide users through the procedure with voice prompts, enabling effective use by individuals without clinical training. The design of AED algorithms involves balancing sensitivity for shockable rhythms against specificity to avoid unnecessary shocks.

Implantable Cardioverter-Defibrillators

An implantable cardioverter-defibrillator (ICD) is a battery-powered device implanted in the chest that continuously monitors cardiac rhythm and delivers a defibrillation shock if a dangerous arrhythmia is detected. ICDs also provide pacing functions to address bradycardia and, in biventricular configurations, cardiac resynchronization therapy for heart failure. The NCBI StatPearls entry on implantable defibrillators summarizes clinical indications, device architecture, and lead configurations.

Modern ICDs communicate wirelessly with external monitoring systems, allowing clinicians to review arrhythmia episodes and device performance remotely. Advances in subcutaneous ICD designs, which place leads under the skin rather than transvenously, eliminate the risks associated with intracardiac leads while maintaining defibrillation capability.

Applications

Defibrillation technology has applications across a range of clinical and public health settings, including:

• Emergency treatment of out-of-hospital cardiac arrest through publicly deployed AEDs
• In-hospital management of ventricular fibrillation and unstable tachyarrhythmias
• Long-term arrhythmia monitoring and therapy through implantable cardioverter-defibrillators
• Cardiac resynchronization therapy for patients with systolic heart failure
• Electrophysiology research into shock-tissue interaction and optimal waveform design